investor.xtantmedical.com

investor.xenon-pharma.com

Investor Overview | Xenon Pharma

From families to genes, from genes to drugs. Xenon Pharmaceuticals Inc at Canaccord Genuity 35th Annual Growth Conference. August 13, 2015. 160;at 10:30 am ET. Xenon Pharmaceuticals Inc at Canaccord Genuity 35th Annual Growth Conference. Thursday, August 13, 2015 . 10:30 am ET  . Click here for webcast. Click here to add this event to your calendar. 160; 1.10. Data as of August 17, 2015 4:00 pm ET. Minimum 20 minute delay. August 10, 2015. There are currently no events scheduled.

investor.xenoport.com

XenoPort, Inc. > Corporate Profile

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. XenoPort is currently commercializing Horizant. Gabapentin enacarbil) Extended-Release Tablets, its first approved product in the United States, and developing a novel fumaric acid ester product candidate, XP23829, as a potential treatment for relapsing-remitting multiple sclerosis and/or psoriasis. U=http:/ ...

investor.xilinx.com

Xilinx.com : Investor Relations

We have detected your current browser version is not the latest one. Xilinx.com uses the latest web technologies to bring you the best online experience possible. Please upgrade to a Xilinx.com supported browser: Chrome. Broadcast and Pro A/V. Showcase of Products Enabled by Xilinx Technology. FPGAs and 3D ICs. Showcase of Products Enabled by Xilinx Technology. Shaping the Future of Next Generation Systems. Vivado Design Suite - HLx Editions. Boards, Kits, and Modules. Xilinx GO Mobile App. Jan 24, 2018.

investor.xlgroup.com

Events | Investor Relations | XL

Separately, XL and Catlin were two strong, innovative companies. Together, we're even stronger. Find out more about XL Catlin. Please do not show me this message again. Catlin Acquisition US Tax Information. Mergers and Acquisition Announcement. XL Group plc Announces Second Quarter 2015 Results. Q2 2015 XL Group plc Earnings Conference Call. XL Group plc Announces $1 Billion Share Buyback Program and Increase in Ordinary Share Dividends from $0.16 to $0.20 per Share. 160;at 10:00 am ET. WORK AT XL GROUP.

investor.xt.pl

xt.pl - This website is for sale! - xt Resources and Information.

The owner of xt.pl. Is offering it for sale for an asking price of 10000 EUR! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.

investor.xtantmedical.com

XTANT Medical | Investors Overview | Investors

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and.

investor.xtentinc.com

xtentinc.com

investor.zans.org

zans.org -&nbspThis website is for sale! -&nbspzans Resources and Information.

investor.zedge.net

The Zedge IR Site

Skip to main content. Annual Report and Proxy. Zedge provides one of the most popular content distribution platforms, worldwide, centered on self-expression. Annual Report and Proxy. Dec 05, 2016. Jan 12, 2017. Statement of Changes in Beneficial Ownership. Dec 08, 2016. Zedge Announces First Quarter Fiscal 2017 Results. We are committed to high standards of corporate governance, business integrity and professionalism. ZEDGE Senior Data Scientist. ZEDGE™ is a trademark of Zedge Inc.

investor.zimmerbiomet.com

Zimmer Biomet -- Investor Relations

Zimmer is now Zimmer Biomet. Zimmer Biomet - Delivering Value. Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Recent News Releases and Information. Zimmer Completes Combination with Biomet.

investor.zixcorp.com

ZixCorp - A Leader in Email Data Protection - Investors - Investors

ZixCorp: E-mail Encryption Service Provider. Email Data Loss Prevention. Information About Our 2015 Annual Meeting of Shareholders and Proxy Statement. Q2 2015 Non-GAAP Reconciliation and Other Metrics. Q1 2015 Non-GAAP Reconciliation and Other Metrics. Q4 2014 Non-GAAP Reconciliation and Other Metrics. Q3 2014 Non-GAAP Reconciliation and Other Metrics. Q2 2014 Non-GAAP Reconciliation and Other Metrics. Quarterly GAAP Non-GAAP Recon Adj for Disc Ops. 160; 0.06. Data as of 08/07/15 4:00 pm ET. Will Remain...